Myth Replacement Therapy: MPs Debate the Science of Mitochondria
By Dr. Ted Morrow,
BioNews
| 09. 08. 2014
The regulatory path to clinical trials of mitochondrial replacement therapy (MRT) was recently debated in the House of Commons. MRT is under development in the UK as way of potentially eliminating mitochondrial disease. The techniques essentially swap diseased mitochondria in the unfertilised or fertilised eggs of affected women for putatively healthy ones obtained from a donor. The outcome is unknown and evidence from animals suggest mismatching may occur between the nuclear DNA from the mother and the mitochondrial DNA (mtDNA) derived from the donor (1). The debate was called by a group of backbenchers that are unhappy about the pace with which the Government is apparently moving towards changing the regulations. The split in views in the chamber was fairly even.
Read more...
Related Articles
By Fyodor Urnov, The CRIPSR Journal | 10.18.2024
The field of clinical gene editing has a bona fide crisis on its hands—a crisis that has to, and can be, promptly resolved.
An outside observer of our field might be surprised by this and say—what crisis? The first...
By Walt Bogdanich and Carson Kessler, The New York Times | 10.23.2024
By 2021, nearly 2,000 volunteers had answered the call to test an experimental Alzheimer’s drug known as BAN2401. For the drugmaker Eisai, the trial was a shot at a windfall — potentially billions of dollars — for defanging a disease...
By Ashleigh Wyss [cites CGS' Katie Hasson], Listnr | 10.09.2024
Discovering your genetic history can be as simple as spitting into a test tube, but what happens when your data ends up in the wrong hands?
With at-home DNA test kits becoming increasingly popular throughout the 2010s, curious consumers have...
By Kevin Davies , Genetic Engineering and Biotechnology News | 10.22.2024